Natco Pharma informs about press release

03 May 2021 Evaluate

Natco Pharma has informed that it has enclosed the Press Release on May 3rd 2021, titled ‘NATCO receives Emergency Use approval for Baricitinib tablets for Covid-19 treatment’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

898.80 -34.80 (-3.73%)
08-Dec-2025 15:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 924.35
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×